These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9527641)

  • 1. Systemic and ocular absorption and antagonist activity of topically applied cyclopentolate in man.
    Haaga M; Kaila T; Salminen L; Ylitalo P
    Pharmacol Toxicol; 1998 Jan; 82(1):19-22. PubMed ID: 9527641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic absorption of ocular cyclopentolate in children.
    Lahdes K; Huupponen R; Kaila T; Ali-Melkkilä T; Salminen L; Saari M
    Ger J Ophthalmol; 1992; 1(1):16-8. PubMed ID: 1477610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic absorption and anticholinergic activity of topically applied tropicamide.
    Vuori ML; Kaila T; Iisalo E; Saari KM
    J Ocul Pharmacol; 1994; 10(2):431-7. PubMed ID: 8083562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations and ocular effects of cyclopentolate after ocular application of three formulations.
    Lahdes K; Huupponen R; Kaila T; Monti D; Saettone MF; Salminen L
    Br J Clin Pharmacol; 1993 May; 35(5):479-83. PubMed ID: 8512760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular effects and systemic absorption of cyclopentolate eyedrops after canthal and conventional application.
    Lahdes KK; Huupponen RK; Kaila TJ
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):698-702. PubMed ID: 7747578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations and antagonist activity of topically applied betaxolol in aqueous humour.
    Vuori ML; Kaila T; Iisalo E; Saari KM
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):677-81. PubMed ID: 7906473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma kinetics and antagonist activity of topical ocular timolol in elderly patients.
    Vuori ML; Kaila T
    Graefes Arch Clin Exp Ophthalmol; 1995 Mar; 233(3):131-4. PubMed ID: 7758979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and aqueous humour concentrations and systemic effects of topical betaxolol and timolol in man.
    Vuori ML; Ali-Melkkilä T; Kaila T; Iisalo E; Saari KM
    Acta Ophthalmol (Copenh); 1993 Apr; 71(2):201-6. PubMed ID: 8333266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of muscarinic receptor modulators on ocular biometry of guinea pigs.
    Fang F; Huang F; Xie R; Li C; Liu Y; Zhu Y; Qu J; Zhou X
    Ophthalmic Physiol Opt; 2015 Jan; 35(1):60-9. PubMed ID: 25376436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic absorption of ophthalmic cyclopentolate.
    Kaila T; Huupponen R; Salminen L; Iisalo E
    Am J Ophthalmol; 1989 May; 107(5):562-4. PubMed ID: 2712146
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption of ocular timolol: drug concentrations and beta-receptor binding activity in the aqueous humour of the treated and contralateral eye.
    Saari KM; Ali-Melkkilä T; Vuori ML; Kaila T; Iisalo E
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):671-6. PubMed ID: 7906472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.
    Mitchell A; Hall RW; Erickson SW; Yates C; Lowery S; Hendrickson H
    Curr Eye Res; 2016 Dec; 41(12):1601-1607. PubMed ID: 27159349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: systemic absorption of topically applied ocular drugs in humans.
    Salminen L
    J Ocul Pharmacol; 1990; 6(3):243-9. PubMed ID: 2290070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses.
    Hehl EM; Beck R; Luthard K; Guthoff R; Drewelow B
    Eur J Clin Pharmacol; 1999 Jun; 55(4):317-23. PubMed ID: 10424326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of topical 1% cyclopentolate on IOLMaster biometry.
    Arici C; Turk A; Ceylan OM; Kola M
    Optom Vis Sci; 2014 Nov; 91(11):1343-7. PubMed ID: 25237761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic absorption of topically applied ocular timolol.
    Kaila T; Salminen L; Huupponen R
    J Ocul Pharmacol; 1985; 1(1):79-83. PubMed ID: 3880069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects on accommodative and pupillary responses by topical application of cyclopentolate hydrochloride].
    Ohmi G; Kinoshita H; Kinoshita S
    Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1099-104. PubMed ID: 1759650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of some macromolecular ionic complexes on the pharmacokinetics and -dynamics of ocular cyclopentolate in rabbits.
    Huupponen R; Kaila T; Saettone MF; Monti D; Ilsalo E; Salminen L; Oksala O
    J Ocul Pharmacol; 1992; 8(1):59-67. PubMed ID: 1402295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of physostigmine for cyclopentolate overdose in an infant.
    Derinoz O; Emeksiz HC
    Pediatrics; 2012 Sep; 130(3):e703-5. PubMed ID: 22908101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.